Kopka; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kopka; Klaus.The latest application filed is for "labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers".

Company Profile

13.14.25

Kopka; Klaus - Dresden DE
KOPKA; Klaus - Desden DE
KOPKA; Klaus - Dossenheim DE
Kopka; Klaus - Muenster N/A DE
Kopka; Klaus - Munster DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Double-labeled probe for molecular imaging and use thereof Grant 11,452,786 - Eder , et al. September 27, 2	2022-09-27
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The Treatment Of Psma-expressing Cancers App 20210393809 - HABERKORN; Uwe ; et al.	2021-12-23
Use Of Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), As Agents For The Treatment Of Prostate Cancer App 20210283279 - EDER; Matthias ; et al.	2021-09-16
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Grant 11,045,564 - Eder , et al. June 29, 2	2021-06-29
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma) As Agents For The Treatment Of Prostate Cancer App 20210177996 - EDER; Matthias ; et al.	2021-06-17
Double-labeled probe for molecular imaging and use thereof Grant 11,020,493 - Eder , et al. June 1, 2	2021-06-01
18f - Tagged Inhibitors Of Prostate Specific Membrane Antigen (psma) And Their Use As Imaging Agents For Prostate Cancer App 20210053922 - CARDINALE; Jens ; et al.	2021-02-25
A Double-labeled Probe For Molecular Imaging And Use Thereof App 20200368374 - EDER; Ann-Christin ; et al.	2020-11-26
A Double-labeled Probe For Molecular Imaging And Use Thereof App 20200353109 - EDER; Matthias ; et al.	2020-11-12
18F--tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Grant 10,815,200 - Cardinale , et al. October 27, 2	2020-10-27
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The T App 20190374660 - EDER; Matthias ; et al.	2019-12-12
Double-labeled Probe For Molecular Imaging And Use Thereof App 20190365931 - Eder; Matthias ; et al.	2019-12-05
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Grant 10,471,160 - Eder , et al. Nov	2019-11-12
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The T App 20190336622 - EDER; Matthias ; et al.	2019-11-07
Double-labeled probe for molecular imaging and use thereof Grant 10,406,246 - Eder , et al. Sept	2019-09-10
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Grant 10,398,791 - Eder , et al. Sep	2019-09-03
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The Treatment Of Prostate Cancer App 20190060491 - EDER; Matthias ; et al.	2019-02-28
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The Treatment Of Prostate Cancer App 20190008988 - EDER; Matthias ; et al.	2019-01-10
18f - Tagged Inhibitors Of Prostate Specific Membrane Antigen (psma) And Their Use As Imaging Agents For Prostate Cancer App 20180194729 - CARDINALE; Jens ; et al.	2018-07-12
18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Grant 10,016,519 - Kopka , et al. July 10, 2	2018-07-10
18f-tagged Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The Treatment Of Prostate Cancer App 20170246327 - KOPKA; Klaus ; et al.	2017-08-31
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma), Their Use As Imaging Agents And Pharmaceutical Agents For The Treatment Of Prostate Cancer App 20160228587 - EDER; Matthias ; et al.	2016-08-11
Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof Grant 9,023,318 - Chen , et al. May 5, 2	2015-05-05
Double-Labeled Probe for Molecular Imaging and Use Thereof App 20150110715 - Eder; Matthias ; et al.	2015-04-23
Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof App 20130217887 - Chen; Gang ; et al.	2013-08-22
5-pyrrolidinylsulfonyl-isatin Derivatives App 20130149239 - Kopka; Klaus ; et al.	2013-06-13
5-pyrrolidinylsulfonyl isatin derivatives Grant 8,440,841 - Kopka , et al. May 14, 2	2013-05-14
Fluorescent Photoprobe For The Imaging Of Endothelin Receptors App 20130004430 - Bremer; Christoph ; et al.	2013-01-03
Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof App 20120282180 - Kolb; Hartmuth C. ; et al.	2012-11-08
Diagnostic imaging agents with MMP inhibitory activity Grant 8,231,858 - Storey , et al. July 31, 2	2012-07-31
Fluorescent photoprobe for the imaging of endothelin receptors Grant 8,212,058 - Bremer , et al. July 3, 2	2012-07-03
Fluorescent Photoprobe For The Imaging Of Endothelin Receptors App 20090169483 - Bremer; Christoph ; et al.	2009-07-02
5-Pyrrolidinylsulfonyl Isatin Derivatives App 20090041664 - Kopka; Klaus ; et al.	2009-02-12
Diagnostic imaging agents with mmp inhibitory activity App 20070071670 - Storey; Anthony ; et al.	2007-03-29
Imaging agents comprising barbituric acid derivatives App 20060120956 - Kopka; Klaus ; et al.	2006-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.